美股異動丨萬國數據盤前跌逾1% Q1業績遜預期 富瑞下調目標價
萬國數據(GDS.US)盤前跌1.05%,報7.53美元。萬國數據曾公佈業績稱,第一季度每ADS虧損1.96元,較去年同期的2.67元虧損收窄,分析師預計虧損1.87元;收入為26.3億元,同比增長9.1%,分析師預計為26.7億元。該公司重申2024年全年收入指引,為113.4億至117.6億元。績後,道明考恩將其目標價從29美元下調至27美元;富瑞集團分析師Edison Lee維持其買入評級,將目標價從17.75美元下調至16.69美元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.